Paxlovid Boceprevir Intermediate CAS 565456-77-1 Assay ≥99.0%
Samar da Kasuwanci PF-07321332 Matsakaici masu alaƙa da Paxlovid tare da Babban inganci
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0] hexane CAS 943516-54-9
Sunan Sinadari | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0] hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Makamantu | Methyl (1R,2S,5S) -6,6-dimethyl-3-azabicyclo[3.1.0] hexane-2-carboxylate Hydrochloride |
Lambar CAS | 565456-77-1 |
Lambar CAT | Saukewa: RF-PI318 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | C9H15NO2.ClH |
Nauyin Kwayoyin Halitta | 205.683 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari zuwa Kashe-Farin Foda |
Identification A | IR: Mai kama da Abun Magana |
Identity B | Lokacin Tsayawa: Kama da Abun Magana |
Enantiomer | ≤0.15% |
Rashin Tsabtace Mai Ma'ana (na HPLC) | |
Rashin Najasa Ba a sani ba | ≤0.20% |
Jimlar ƙazanta | ≤1.0% |
Ruwa | ≤0.50% |
Ragowa akan Ignition | ≤0.10% |
Karfe masu nauyi | ≤20ppm |
Assay | ≥99.0% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin PF-07321332 Paxlovid (CAS 2628280-40-8) da Boceprevir (CAS 394730-60-0) |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
(1R,2S,5S) -6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) wani azabicyclohexane abin da ake amfani da shi a cikin shiri na hepatitis C. kwayar cutar (HCV) NS3 serine protease inhibitor.Matsakaicin PF-07321332 Paxlovid (CAS 2628280-40-8) da Boceprevir (CAS 394730-60-0).PF-07321332 mai ƙarfi ne kuma mai hanawa SARS-CoV 3C-kamar protease (3CLPRO).PF-07321332 yana hari ga ƙwayar cuta ta SARS-CoV-2 kuma ana iya amfani dashi don binciken COVID-19.Boceprevir (INN, sunan kasuwanci Victrelis) mai hana protease ne da ake amfani dashi azaman magani ga cutar hanta C genotype 1. Yana ɗaure zuwa wurin aiki na HCV mara tsari na 3 NS3 (HCV).Schering-Plough ne ke haɓaka shi, amma yanzu Merck ne ke haɓaka shi tun lokacin da aka sayi Schering a cikin 2009. FDA ta amince da shi a ranar 13 ga Mayu, 2011.